Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$363M |
| 2 |
Nike
NKE
|
+$289M |
| 3 |
Home Depot
HD
|
+$271M |
| 4 |
Mastercard
MA
|
+$180M |
| 5 |
Amazon
AMZN
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$226M |
| 2 |
Coca-Cola
KO
|
+$225M |
| 3 |
Meta Platforms (Facebook)
META
|
+$205M |
| 4 |
Johnson & Johnson
JNJ
|
+$199M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.84% |
| 2 | Healthcare | 12.18% |
| 3 | Financials | 11.43% |
| 4 | Industrials | 9.05% |
| 5 | Consumer Discretionary | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Ally Financial
ALLY
$13.6B
| $11.1M | 0.02% |
652,400
+570,400
| +696% | +$9.85M |
|
|
DCP
1077
DELISTED
DCP Midstream, LP
DCP
| $11.1M | 0.02% |
321,710
+272,300
| +551% | +$8.95M |
|
1078
Honeywell
HON
$74.6B
| $11.1M | 0.02% |
106,059
-798,057
| -88% | -$82M |
|
1079
Wayfair
W
$13.9B
| $11.1M | 0.02% |
283,500
+226,800
| +400% | +$9.05M |
|
1080
ON Semiconductor
ON
$31.8B
| $11M | 0.02% |
1,252,696
+897,400
| +253% | +$8.54M |
|
1081
Alexandria Real Estate Equities
ARE
$8.27B
| $11M | 0.02% |
106,500
-198,317
| -65% | -$18.9M |
|
|
VCRA
1082
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $11M | 0.02% |
857,800
-72,300
| -8% | -$869K |
|
|
CMBT
1083
CMB.TECH NV
CMBT
$4.92B
| $11M | 0.02% |
1,201,100
+173,000
| +17% | +$1.77M |
|
|
NPTN
1084
DELISTED
NEOPHOTONICS CORP
NPTN
| $11M | 0.02% |
1,152,700
-15,300
| -1% | -$167K |
|
1085
Onto Innovation
ONTO
$20.6B
| $10.9M | 0.02% |
526,100
+161,600
| +44% | +$2.85M |
|
|
STL
1086
DELISTED
Sterling Bancorp
STL
| $10.9M | 0.02% |
695,593
-469,000
| -40% | -$7.52M |
|
1087
SunCoke Energy
SXC
$801M
| $10.9M | 0.02% |
1,876,124
+151,815
| +9% | +$958K |
|
1088
Q2 Holdings
QTWO
$4.13B
| $10.9M | 0.02% |
389,500
-71,400
| -15% | -$1.79M |
|
1089
Preferred Bank
PFBC
$1.26B
| $10.9M | 0.02% |
376,555
-9,800
| -3% | -$305K |
|
|
TVTY
1090
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $10.8M | 0.02% |
938,800
+96,811
| +11% | +$1.13M |
|
|
BSTC
1091
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $10.8M | 0.02% |
271,400
+22,200
| +9% | +$813K |
|
1092
Inogen
INGN
$154M
| $10.8M | 0.02% |
216,300
-146,900
| -40% | -$7M |
|
|
NSU
1093
DELISTED
Nevsun Resources Ltd.
NSU
| $10.8M | 0.02% |
3,684,800
+453,609
| +14% | +$1.5M |
|
1094
Acuity Brands
AYI
$10.8B
| $10.8M | 0.02% |
+43,671
| New | +$10.9M |
|
|
BPFH
1095
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $10.8M | 0.02% |
917,100
+92,900
| +11% | +$1.12M |
|
1096
ConocoPhillips
COP
$150B
| $10.7M | 0.02% |
+246,513
| New | +$10.9M |
|
1097
Icon
ICLR
$12.9B
| $10.7M | 0.02% |
153,400
+87,700
| +133% | +$6.02M |
|
|
SODA
1098
DELISTED
SodaStream International Ltd
SODA
| $10.7M | 0.02% |
503,300
+73,800
| +17% | +$1.31M |
|
1099
Genpact
G
$5.7B
| $10.7M | 0.02% |
399,600
-453,500
| -53% | -$12.5M |
|
|
ABAX
1100
DELISTED
Abaxis Inc
ABAX
| $10.7M | 0.02% |
226,871
+22,352
| +11% | +$1.01M |
|
Similar funds
Jim Simons's Q2 2016 Portfolio in Review
As of Q2 2016, Jim Simons held 3,774 positions worth $52.5B, down 0.13% from $52.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
Jim Simons withdrew a net $1.64B in Q2 2016, closing 474 positions and reducing 1,158 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Jim Simons opened a new position in Nike worth $280M.
- Jim Simons's largest Q2 2016 buy was Nike: 5,066,500 shares worth $280M.
- Jim Simons added most to CVS Health in Q2 2016, an estimated $363M increase.
- Jim Simons's biggest Q2 2016 reduction was PepsiCo, cutting an estimated $226M.
- Jim Simons fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 8% of its $52.5B portfolio in Q2 2016.
- Jim Simons opened 423 new positions and closed 474 in Q2 2016.
- Jim Simons's portfolio value fell 0.13% quarter-over-quarter to $52.5B.
Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.